Medicare Enrolled

Dr. Daniel Jacobs, M.D.

Neurology · Orlando, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3849 OAKWATER CIRCLE, Orlando, FL 32806
4072401762
In practice since 2005 (20 years)
NPI: 1356323166 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jacobs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobs? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jacobs

Dr. Daniel Jacobs is a neurology in Orlando, FL, with 20 years in practice. Based on federal Medicare data, Dr. Jacobs performed 15,986 Medicare services across 813 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jacobs received a total of $28,718 from 86 pharmaceutical and/or device companies across 1452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jacobs is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 7% volume in FL$ $28,718 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,986
Medicare services
Top 7% in FL for neurology
813
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~799 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Ocrelizumab infusion (Ocrevus) for MS14,400$43$162
Office visit, established patient, complex (40-54 min)670$132$302
New patient office visit, complex (60-74 min)125$164$434
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour119$16$110
Needle measurement of electrical activity in arm or leg muscles, complete study113$75$175
Injection of additional new drug or substance into vein99$12$68
Administration of chemotherapy into vein, 1 hour or less93$94$600
Office visit, established patient (30-39 min)76$94$225
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less72$49$210
Injection, methylprednisolone sodium succinate, up to 125 mg51$4$20
Injection, diphenhydramine hcl, up to 50 mg49$1$2
Administration of chemotherapy into vein, each additional hour44$21$130
EEG, extended monitoring32$334$550
Nerve conduction, 7-8 studies24$135$300
Nerve conduction, 9-10 studies19$163$450
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
91.3% high complexity
2.3% medium
6.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$28,718
Total received (2018-2024)
Avg $4,103/year across 7 years
Top 12% in FL for neurology
86
Companies
1,452
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,658 (78.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,108 (10.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,952 (10.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,301
2023
$7,524
2022
$5,453
2021
$3,641
2020
$3,573
2019
$3,389
2018
$1,837

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$3,347
GENZYME CORPORATION
$1,990
Horizon Therapeutics plc
$1,804
ACADIA Pharmaceuticals Inc
$1,473
Biogen, Inc.
$1,440
Genentech USA, Inc.
$1,265
Novartis Pharmaceuticals Corporation
$1,258
ABBVIE INC.
$1,142
EMD Serono, Inc.
$1,043
Teva Pharmaceuticals USA, Inc.
$954
Allergan, Inc.
$928
Banner Life Sciences, LLC
$867
Alexion Pharmaceuticals, Inc.
$750
Amgen Inc.
$747
Lilly USA, LLC
$720
UCB, Inc.
$712
Harmony Biosciences LLC
$548
JAZZ PHARMACEUTICALS INC.
$532
Sunovion Pharmaceuticals Inc.
$370
TG THERAPEUTICS, INC.
$329
Celgene Corporation
$327
PFIZER INC.
$294
Allergan Inc.
$267
Amneal Pharmaceuticals LLC
$265
US WorldMeds, LLC
$234
AbbVie Inc.
$228
Takeda Pharmaceuticals U.S.A., Inc.
$218
TG Therapeutics, Inc.
$217
CSL Behring
$205
Acorda Therapeutics, Inc
$197
GE HEALTHCARE
$186
Eisai Inc.
$182
CATALYST PHARMACEUTICALS, INC.
$178
Grifols USA, LLC
$175
Vanda Pharmaceuticals Inc.
$172
Neurocrine Biosciences, Inc.
$169
Supernus Pharmaceuticals, Inc.
$165
Janssen Pharmaceuticals, Inc
$159
ANI Pharmaceuticals, Inc.
$155
Mallinckrodt Enterprises LLC
$151
Alnylam Pharmaceuticals Inc.
$147
Lundbeck LLC
$146
BIOTRONIK INC.
$139
Biohaven Pharmaceutical Holding Company Ltd.
$104
BANNER LIFE SCIENCES, LLC
$96
Corium, LLC
$88
Jazz Pharmaceuticals Inc.
$85
UPSHER-SMITH LABORATORIES LLC
$80
Adamas Pharmaceuticals, Inc.
$79
Avadel CNS Pharmaceuticals, LLC
$76
Mallinckrodt Hospital Products Inc.
$74
Avion Pharmaceuticals
$70
MDD US Operations, LLC
$66
Merz Pharmaceuticals, LLC
$64
Upsher-Smith Laboratories LLC
$64
E.R. Squibb & Sons, L.L.C.
$60
Axsome Therapeutics, Inc.
$59
Kyowa Kirin, Inc.
$58
AstraZeneca Pharmaceuticals LP
$56
GE Healthcare
$55
Mallinckrodt LLC
$54
Boston Scientific Corporation
$47
Impax Laboratories, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$40
Strongbridge US INC.
$40
Abbott Laboratories
$39
Bayer HealthCare Pharmaceuticals Inc.
$38
Otsuka America Pharmaceutical, Inc.
$36
Exeltis, USA Inc.
$32
IDORSIA PHARMACEUTICALS US INC
$29
Avanir Pharmaceuticals, Inc.
$29
REVANCE THERAPEUTICS, INC.
$25
Inspire Medical Systems, Inc.
$22
Harmony Biosciences Llc
$20
Biohaven Pharmaceuticals, Inc.
$20
MITSUBISHI TANABE PHARMA AMERICA, INC.
$20
Xeris Pharmaceuticals, Inc.
$19
Medtronic USA, Inc.
$19
Akcea Therapeutics, Inc.
$17
HARMONY BIOSCIENCES LLC
$16
Medtronic Vascular, Inc.
$15
Promius Pharma LLC
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Piramal Imaging Limited
$13
ARBOR PHARMACEUTICALS, INC.
$13
Zyla Life Sciences
$12
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Activase · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BIOMONITOR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Bafiertam · Betaseron · Briviact · CINQAIR · COMIRNATY · COPAXONE · DAXXIFY · DAYBUE · DISEASE STATE · DUOPA · Dhivy · EMGALITY · Enspryng · Evrysdi · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LUMRYZ · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUVIVIQ · RADICAVA · REXULTI · RYTARY · Rebif · Repatha · Reveal LINQ · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Soliris · Solitaire · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · WAKIX · Wakix · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (79%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $180 per 100 Medicare services performed
Looking for a neurology in Orlando?
Compare neurologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
92
Per 100K population
6.4
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jacobs is a mixed practice specialist, with above-average Medicare volume (top 7% in FL), and high industry engagement (low-engagement, top 12%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jacobs experienced with ocrelizumab infusion (ocrevus) for ms?
Based on Medicare claims data, Dr. Jacobs performed 14,400 ocrelizumab infusion (ocrevus) for ms services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jacobs receive payments from pharmaceutical companies?
Yes. Dr. Jacobs received a total of $28,718 from 86 companies across 1,452 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobs's costs compare to other neurologys in Orlando?
Dr. Jacobs's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →